Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaclotide plus ultra-low-volume PEG for bowel preparation in low-risk adults undergoing colonoscopy
ChiCTR2500101833Phase 4Not yet recruiting
- Sponsor
- Third People's Hospital of Chengdu
- Start
- Apr 2025
- Modality
- Peptides, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of linaclotide and macrogol in bowel preparation (2 arms), sponsored by Third People's Hospital of Chengdu. Primary endpoint: Rate of adequate bowel preparation. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
linaclotidemacrogol
03
Conditions
bowel preparation
Beyond the preview
Go deeper on ChiCTR2500101833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500101833.